Bio Break: Real-Time Imaging for Targeted Drug Delivery

Resources

Bio Break: Real-Time Imaging for Targeted Drug Delivery

In this episode of Bio Break, Nick and Joris discuss the fascinating world of real-time imaging for targeted drug delivery. When delivering drugs to precise locations in the body, how do we ensure they reach the right spot? The answer lies in medical imaging technologies such as MRI, CT, and ultrasound, which play a crucial role in guiding complex drug delivery devices.

Nick starts by asking how imaging technologies help visualize drug targeting during delivery. Joris explains that MRI (Magnetic Resonance Imaging), CT (Computed Tomography), and ultrasound are the three most commonly used imaging techniques. Each has its advantages and limitations depending on the application.

  • MRI offers exceptional resolution and is ideal for deep-tissue targeting, such as brain delivery for conditions like Parkinson’s disease. However, intraoperative MRI machines are less accessible in hospitals, making their real-time use challenging.
  • CT scanning is more widely available and excellent for bone-related targeting, such as spinal drug delivery. While it has slightly lower resolution than MRI, it is a practical and widely adopted solution in medical settings.
  • Ultrasound is the most real-time imaging method and is commonly used for nerve blocks and pain management. However, it has depth limitations and is ineffective for regions behind bone, such as the brain.

Nick and Joris also discuss the future of medical imaging in drug delivery. With advancements in 3D imaging and computational modeling, physicians will soon have better spatial awareness of the drug delivery process, improving precision and patient outcomes.

As medical imaging evolves, AI-driven technologies and 3D imaging integration will revolutionize precision drug delivery, making it more efficient and accessible.

Real-Time Imaging for Targeted Drug Delivery

YouTube video thumbnail
Thumbnail showing gene therapy delivery challenge with disrupted DNA pathway

In this episode of MedDevice by Design, Ariana Wilson and Mark Drlik explore what sits beneath that progress, focusing on how these therapies are delivered and why delivery remains one of the hardest problems to solve.

Indirect ELISA explained with antibody model showing enzyme linked immunoassay detection

Nick and Nigel walk through how indirect ELISA works, why it uses two antibodies instead of one, and when this approach makes the most sense in real diagnostic workflows.

Smartwatch displaying heart rate and ECG-style waveform, illustrating the difference between wellness devices and medical devices in digital health regulation

Ariana Wilson and Mark Drlik break down medical vs wellness devices and explain why two products with identical hardware can fall into completely different regulatory categories.

Nick from StarFish Medical demonstrating antigen detection using a toy antibody model to explain how monoclonal antibodies bind antigens in ELISA diagnostics

Nick and Nigel break down the ELISA assay explained in simple, practical terms using everyday models.